Locations
Ahmedabad, Gujarat, India · Cambridge, MA, USA
industry
Biotechnology · DeepTech · Health · Manufacturing
Size
51-200 employees
Stage
Series B
founded in
2008
Axio Biosolutions is a medtech company specializing in advanced surgical and wound care solutions. It is recognized as the first Indian company to receive US FDA clearance for a wound care/hemostat product, Axiostat, which is designed to control life-threatening bleeding from traumatic injuries. The company leverages its expertise in biomaterials, particularly chitosan, to create innovative products that prioritize patient comfort and effectiveness in managing trauma, surgical, and chronic wounds. With a strong focus on research and development, Axio aims to revolutionize wound care globally, catering to military, emergency, and dental applications, and has established a significant market presence.
Something looks off?On-site & Remote